These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Yeast as a model for medical and medicinal research. Mager WH; Winderickx J Trends Pharmacol Sci; 2005 May; 26(5):265-73. PubMed ID: 15860374 [TBL] [Abstract][Full Text] [Related]
45. Cellular and molecular engineering of yeast Saccharomyces cerevisiae for advanced biobutanol production. Kuroda K; Ueda M FEMS Microbiol Lett; 2016 Feb; 363(3):. PubMed ID: 26712533 [TBL] [Abstract][Full Text] [Related]
46. Data-driven multiscale modeling reveals the role of metabolic coupling for the spatio-temporal growth dynamics of yeast colonies. Intosalmi J; Scott AC; Hays M; Flann N; Yli-Harja O; Lähdesmäki H; Dudley AM; Skupin A BMC Mol Cell Biol; 2019 Dec; 20(1):59. PubMed ID: 31856706 [TBL] [Abstract][Full Text] [Related]
48. Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p. Moxley JF; Jewett MC; Antoniewicz MR; Villas-Boas SG; Alper H; Wheeler RT; Tong L; Hinnebusch AG; Ideker T; Nielsen J; Stephanopoulos G Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6477-82. PubMed ID: 19346491 [TBL] [Abstract][Full Text] [Related]
49. The Saccharomyces cerevisiae W303-K6001 cross-platform genome sequence: insights into ancestry and physiology of a laboratory mutt. Ralser M; Kuhl H; Ralser M; Werber M; Lehrach H; Breitenbach M; Timmermann B Open Biol; 2012 Aug; 2(8):120093. PubMed ID: 22977733 [TBL] [Abstract][Full Text] [Related]
50. Transmembrane signaling in Saccharomyces cerevisiae as a model for signaling in metazoans: state of the art after 25 years. Engelberg D; Perlman R; Levitzki A Cell Signal; 2014 Dec; 26(12):2865-78. PubMed ID: 25218923 [TBL] [Abstract][Full Text] [Related]
51. Yeast-based screening platforms to understand and improve human health. Deichmann M; Hansson FG; Jensen ED Trends Biotechnol; 2024 Oct; 42(10):1258-1272. PubMed ID: 38677901 [TBL] [Abstract][Full Text] [Related]
52. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion]. Ishikawa T Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880 [TBL] [Abstract][Full Text] [Related]
53. André Goffeau's imprinting on second generation yeast "genomologists". Fairhead C; Fischer G; Liti G; Neuvéglise C; Schacherer J Yeast; 2019 Apr; 36(4):167-175. PubMed ID: 30645763 [TBL] [Abstract][Full Text] [Related]
54. Natural and modified promoters for tailored metabolic engineering of the yeast Saccharomyces cerevisiae. Hubmann G; Thevelein JM; Nevoigt E Methods Mol Biol; 2014; 1152():17-42. PubMed ID: 24744025 [TBL] [Abstract][Full Text] [Related]
55. Yeast as a cell factory: current state and perspectives. Kavšček M; Stražar M; Curk T; Natter K; Petrovič U Microb Cell Fact; 2015 Jun; 14():94. PubMed ID: 26122609 [TBL] [Abstract][Full Text] [Related]
56. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders. Ocampo A; Barrientos A Biotechniques; 2008 Oct; 45(4):vii-xiv. PubMed ID: 18855765 [TBL] [Abstract][Full Text] [Related]
57. The importance of compartmentalization in metabolic flux models: yeast as an ecosystem of organelles. Klitgord N; Segrè D Genome Inform; 2010 Jan; 22():41-55. PubMed ID: 20238418 [TBL] [Abstract][Full Text] [Related]
58. Human G protein-coupled receptor studies in Saccharomyces cerevisiae. Liu R; Wong W; IJzerman AP Biochem Pharmacol; 2016 Aug; 114():103-15. PubMed ID: 26920251 [TBL] [Abstract][Full Text] [Related]
59. Systems biology of lipid metabolism: from yeast to human. Nielsen J FEBS Lett; 2009 Dec; 583(24):3905-13. PubMed ID: 19854183 [TBL] [Abstract][Full Text] [Related]
60. Systematic planning of genome-scale experiments in poorly studied species. Guan Y; Dunham M; Caudy A; Troyanskaya O PLoS Comput Biol; 2010 Mar; 6(3):e1000698. PubMed ID: 20221257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]